Insulin cost cap splits Democrats seeking broad drug price curbs

Bloomberg

24 February 2022 - ‘Partial solution’ seen problematic as elections loom.

Senate Democrats are testing whether a cap on what many Americans pay for insulin medication can muster bipartisan support, even as advocates for reining in drug prices differ over strategy.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing